Search for: "Generics International (US) Inc" Results 3101 - 3120 of 9,123
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Jan 2014, 10:00 am
The concept is used to describe the fact that fragmentation into an increasing number of international regimes with overlapping areas of competence can lead to contradictory decisions or mutual obstruction. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at… [read post]
12 May 2015, 2:43 pm by James Galvin
Notably, the issuers of RCNs are generally large financial institutions, such as Bank of Montreal, while the investor is typically an unsophisticated individual who is attracted by the high coupon rate and doesn’t understand the level of risk that comes with these highly complex structured investments. [read post]
3 Oct 2017, 5:10 am
Last week, in In Re Smith International Inc. (16here) the patent owner and the patent examiner (reexamination) differed as to the proper definition of “body” in the context of a downhole drilling tool. [read post]
14 Jan 2020, 9:50 am by Mike Worgul
For example, the user may change the name from AAA Office Services, Inc. to AAA Office Service, LLC. [read post]
29 Dec 2010, 10:04 am by Beth Graham
If you are interested in submitting materials for Disputing, please e-mail us at: beth@karlbayer.com. [read post]